company background image
300937 logo

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical SZSE:300937 Stock Report

Last Price

CN¥28.60

Market Cap

CN¥2.7b

7D

-9.6%

1Y

-8.4%

Updated

21 Dec, 2024

Data

Company Financials

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

SZSE:300937 Stock Report

Market Cap: CN¥2.7b

My Notes

Capture your thoughts, links and company narrative

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sichuan Hezong Medicine Easy-to-buy Pharmaceutical
Historical stock prices
Current Share PriceCN¥28.60
52 Week HighCN¥37.53
52 Week LowCN¥17.83
Beta0.14
1 Month Change-1.89%
3 Month Change55.01%
1 Year Change-8.36%
3 Year Change-33.22%
5 Year Changen/a
Change since IPO-28.39%

Recent News & Updates

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Nov 12
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Sep 27
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Recent updates

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Nov 12
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Sep 27
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Jun 07
Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Apr 17
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Shareholder Returns

300937CN Consumer RetailingCN Market
7D-9.6%-6.3%-1.2%
1Y-8.4%5.8%11.8%

Return vs Industry: 300937 underperformed the CN Consumer Retailing industry which returned 5.8% over the past year.

Return vs Market: 300937 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 300937's price volatile compared to industry and market?
300937 volatility
300937 Average Weekly Movement12.7%
Consumer Retailing Industry Average Movement8.6%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 300937's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300937's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20071,114Shunjun Chenwww.hezongyy.com

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. distributes generic drugs and Chinese medicines in China. The company offers medications in the areas of respiratory, anti-inflammatory, five senses, skin and external, digestive, hepatobiliary system, rehabilitation and tranquility, women, pediatrics, cardiovascular and neurological, endocrine system, rheumatoid bone injury, and others.

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Fundamentals Summary

How do Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's earnings and revenue compare to its market cap?
300937 fundamental statistics
Market capCN¥2.74b
Earnings (TTM)CN¥23.31m
Revenue (TTM)CN¥4.45b

117.4x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300937 income statement (TTM)
RevenueCN¥4.45b
Cost of RevenueCN¥4.11b
Gross ProfitCN¥348.14m
Other ExpensesCN¥324.84m
EarningsCN¥23.31m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.24
Gross Margin7.82%
Net Profit Margin0.52%
Debt/Equity Ratio31.8%

How did 300937 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

88%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution